v3.25.2
Revenue Recognition from Collaboration and License Agreements - Schedule of Revenue From Collaboration and License Agreements (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Disaggregation of Revenue [Line Items]        
Revenue from collaboration and license agreements $ 250 $ 1,073 $ 250 $ 53,477
Bristol-Myers Squibb Company        
Disaggregation of Revenue [Line Items]        
Revenue from collaboration and license agreements 250 0 250 2,589
Roche        
Disaggregation of Revenue [Line Items]        
Revenue from collaboration and license agreements $ 0 $ 1,073 $ 0 $ 50,888